JP2013539032A5 - - Google Patents

Download PDF

Info

Publication number
JP2013539032A5
JP2013539032A5 JP2013530408A JP2013530408A JP2013539032A5 JP 2013539032 A5 JP2013539032 A5 JP 2013539032A5 JP 2013530408 A JP2013530408 A JP 2013530408A JP 2013530408 A JP2013530408 A JP 2013530408A JP 2013539032 A5 JP2013539032 A5 JP 2013539032A5
Authority
JP
Japan
Prior art keywords
antibodies
lyme disease
ospf
ospc
ospa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013530408A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013539032A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/053359 external-priority patent/WO2012047607A2/en
Publication of JP2013539032A publication Critical patent/JP2013539032A/ja
Publication of JP2013539032A5 publication Critical patent/JP2013539032A5/ja
Pending legal-status Critical Current

Links

JP2013530408A 2010-09-27 2011-09-27 ライム病の診断方法 Pending JP2013539032A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38669410P 2010-09-27 2010-09-27
US61/386,694 2010-09-27
PCT/US2011/053359 WO2012047607A2 (en) 2010-09-27 2011-09-27 Methods for diagnosing lyme disease

Publications (2)

Publication Number Publication Date
JP2013539032A JP2013539032A (ja) 2013-10-17
JP2013539032A5 true JP2013539032A5 (enExample) 2014-11-20

Family

ID=45928310

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013530408A Pending JP2013539032A (ja) 2010-09-27 2011-09-27 ライム病の診断方法

Country Status (11)

Country Link
US (1) US8946393B2 (enExample)
EP (1) EP2622346A4 (enExample)
JP (1) JP2013539032A (enExample)
KR (1) KR20130101067A (enExample)
CN (1) CN103229055A (enExample)
BR (1) BR112013007329A2 (enExample)
CA (1) CA2812759A1 (enExample)
MX (1) MX2013003609A (enExample)
RU (1) RU2013118647A (enExample)
WO (1) WO2012047607A2 (enExample)
ZA (1) ZA201302402B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT106942B (pt) 2013-05-15 2020-09-10 STAB VIDA, Investigação e Serviços em Ciências Biológicas, Lda Biochip (1) e bouquet de 16 antigénios (2) para a deteção da doença de lyme aguda e crónica
US10457721B2 (en) 2014-08-11 2019-10-29 University Of Massachusetts Anti-OSPA antibodies and methods of use
CN104374921B (zh) * 2014-11-21 2016-09-07 安徽医科大学 一种用于莱姆病鞭毛抗原免疫血清学诊断的蛋白质芯片及其制备方法和应用
AU2016328277B2 (en) 2015-09-25 2022-11-24 Biopeptides Corp. Compositions and methods for diagnosing lyme disease and for predicting lyme disease spirochete elimination after treatment
CN105524989A (zh) * 2015-12-31 2016-04-27 中国疾病预防控制中心传染病预防控制所 用于检测莱姆病螺旋体的rpa引物和探针及检测方法
CN105628918A (zh) * 2016-02-04 2016-06-01 浙江大学 一种蜱传莱姆病伯氏疏螺旋体检测试剂及应用
US20220034880A1 (en) * 2018-10-01 2022-02-03 The Board Of Trustees Of The Leland Stanford Junior University High specificity and sensitivity immunosorbent diagnostic assays with simultaneous resolution of multiple antibody isotypes
US20210215715A1 (en) * 2020-01-10 2021-07-15 Quidel Corporation Test strip with structured substrate for multiplex lateral flow assay for disease diagnostics
EP4136251A4 (en) * 2020-04-13 2024-10-02 ID-Fish Technology, Inc. DETECTION OF LYME DISEASE
US20230324382A1 (en) * 2022-02-01 2023-10-12 Trustees Of Tufts College Antiphospholipid antibodies for the diagnosis of lyme disease

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK590288D0 (da) 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
US6300101B1 (en) 1988-10-24 2001-10-09 Board Of Regents, The University Of Texas System Methods and compositions including a 13kD B. burgdorferi protein
US5777095A (en) * 1988-10-24 1998-07-07 Symbicom Aktiebolag Osp A and B Sequence of Borrelia burgdonferi strains ACA1 and IP90
US6143872A (en) * 1988-10-24 2000-11-07 Symbicom Aktiebolag Borrelia burdorferi Osp A and B proteins and immunogenic peptides
US6872550B1 (en) * 1991-07-11 2005-03-29 Baxter Vaccine Ag Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
US6676942B1 (en) 1991-08-15 2004-01-13 Smithkline Beecham Biologicals (S.A.) Osp a proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines
US6248562B1 (en) * 1993-11-01 2001-06-19 Research Foundation State University Of New York Chimeric proteins comprising borrelia polypeptides and uses therefor
US7008625B2 (en) * 1993-11-01 2006-03-07 Research Foundation Of The State University Of New York Recombinant constructs of Borrelia burgdorferi
US5620862A (en) 1993-11-24 1997-04-15 University Of Connecticut Methods for diagnosing early Lyme disease
PT757556E (pt) * 1994-04-11 2006-10-31 Wyeth Corp Bacterina borrelia burgdorferi
US5558993A (en) * 1994-06-17 1996-09-24 The Regents Of The University Of California Cloned Borrelia burgdorferi virulence protein
CZ42497A3 (en) * 1994-08-17 1997-10-15 Max Planck Gesellschaft VACCINE CONTAINING BORRELIA BURGDORFERI OspG
US5853987A (en) * 1995-04-24 1998-12-29 The Texas A & M University System Decorin binding protein compositions and methods of use
WO1997015600A1 (en) 1995-10-26 1997-05-01 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Tick (ixodes scapularis) vector saliva-induced lyme disease spirochete (borrelia burgdorferi) antigens as vaccine candidates
CA2253374C (en) * 1996-05-02 2004-07-20 Marianne Jartved Mathiesen Novel osp-c derived peptide fragments
US6716574B2 (en) * 1996-05-02 2004-04-06 Dako A/S Osp-C derived peptide fragments
US6902893B1 (en) 1997-06-20 2005-06-07 Gil H. Choi Lyme disease vaccines
CA2294701C (en) 1997-06-30 2009-09-08 The Administrators Of The Tulane Educational Fund Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease
US6610838B1 (en) * 1997-09-10 2003-08-26 Symbicom Aktiebolag P13 antigens from Borrelia
EP1100922B1 (en) 1998-07-31 2008-02-20 Gundersen Lutheran Medical Foundation, Inc. Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine
WO2000018791A1 (en) * 1998-09-29 2000-04-06 Statens Serum Institut Ligand presenting assembly (lpa), method of preparation and uses thereof
US6475492B1 (en) 1999-04-28 2002-11-05 The Administrators Of The Tulane Educational Fund Peptides and assays for the diagnosis of lyme disease
AU5622800A (en) * 1999-06-18 2001-01-09 Med Immune, Inc. Combined decorin binding protein and outer surface protein compositions and methods of use
US20030134345A1 (en) * 2001-07-17 2003-07-17 Michael Brunner Serological assay for detection of antigens sequested within immune complexes
FI112544B (fi) * 2001-11-26 2003-12-15 Bortech Oy Menetelmä varhais- ja myöhäisvaiheen Lymen borrelioosin diagnosoimiseksi
US20050058661A1 (en) 2002-10-18 2005-03-17 Sykes Kathryn F. Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the genus Borrelia
US8821893B2 (en) * 2004-07-02 2014-09-02 Bio Peptides, Corp. Oral vaccine for Borrelia
US7390626B2 (en) 2005-02-25 2008-06-24 Immunosciences Lab., Inc. Methods and kit for diagnosing tick borne illnesses
CN101374858A (zh) * 2005-11-29 2009-02-25 弗吉尼亚州立大学 多价嵌合ospc疫苗原及诊断抗原
EP1957520A4 (en) * 2005-11-29 2009-05-27 Univ Virginia Commonwealth POLYVALENTIC CHIMERIC OSPC VACCINOGEN AND DIAGNOSTIC ANTIGEN
WO2007133623A2 (en) 2006-05-10 2007-11-22 Biopeptides Corporation Peptide diagnostic agent for lyme disease
CN101516905A (zh) 2006-09-15 2009-08-26 英特塞尔股份公司 疏螺旋体属抗原
EP2191266A4 (en) 2007-09-07 2011-08-03 Univ California BORRELIA DIAGNOSTIC AND SCREENING METHOD
US20110105355A1 (en) 2008-04-22 2011-05-05 Research Foundation Of State University Of New York Borrelia burgdorferi cell envelope protein array
US8565892B2 (en) * 2009-10-31 2013-10-22 Qteris, Inc. Nanoparticle-sized magnetic absorption enhancers having three-dimensional geometries adapted for improved diagnostics and hyperthermic treatment
US20130085076A1 (en) * 2009-12-01 2013-04-04 Temple Douglas Borrelia burgdorferi bacterial antigen diagnosic test using polymeric bait containing capture particles
CN103237901B (zh) 2010-03-01 2016-08-03 卡里斯生命科学瑞士控股有限责任公司 用于治疗诊断的生物标志物

Similar Documents

Publication Publication Date Title
JP2013539032A5 (enExample)
RU2013118647A (ru) Способы диагностики болезни лайма
US9207233B2 (en) ELISPOT method having two filter systems
JP2010514805A5 (enExample)
JP5805368B2 (ja) Ｉｐ−１０に基づく免疫学的モニタリング
JP2011509676A5 (enExample)
NZ619883A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
Sahu et al. Current approaches for the detection of Coxiella burnetii infection in humans and animals
WO2007117444A3 (en) Protein detection by aptamers
JP2010115195A5 (enExample)
EA201291314A1 (ru) Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
NZ600828A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EA201290629A1 (ru) Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
AR085282A1 (es) Antigeno de maduracion de celulas b que se utiliza para fines diagnosticos y terapeuticos
JP2011515091A5 (enExample)
JP2017505436A5 (enExample)
JP2009524829A5 (enExample)
BR112013021056A2 (pt) anticorpo monoclonal, linhagem de células de hibridoma, kit para diagnóstico, métodos para a produção de um anticorpo monoclonal e de um agente de ligação, agente de ligação sequência de aminoácidos purificada, método para a obtenção de uma sequência do ácido nucleico codificante, molécula do ácido nucleico isolado codificante, vetor, célula hospedeira isolada, proteína de fusão, método de triagem para a presença de uma doença, de uma condição, métodos de diagnóstico de um indivíduo, de prognóstico para um indivíduo, e de monitoramento de um indivúdo, e, método para detecção da presença ou ausência de um câncer cervical
JP2024096748A (ja) アルファ－シヌクレイン病のアッセイ、方法、及び治療
WO2015054319A9 (en) Method, kits and materials for detection of lyme disease borrelia sp. infection
JP2007533985A5 (enExample)
JP2016526167A5 (enExample)
JP2013506837A5 (enExample)
JP2024059621A (ja) がんの診断及び治療のための組成物及び方法
JP2011518338A5 (enExample)